SEER Research and Charts

SEER - Seer Inc Ordinary Shares - Class A (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2026-02-10)

Last 1.77	Change ⇓ -0.04 (-2.21%)	Volume 316,349
	Open 1.82	High 1.84	Low 1.70

8EMA (Daily) 1.80	40EMA (Daily) 1.87	50EMA (Daily) 1.88	STO (Daily) 24.590	MACD Hist (Daily) -0.009
8EMA (Weekly) 1.842	40EMA (Weekly) 2.00	50EMA (Weekly) 2.03	STO (Weekly) 15.919	MACD Hist (Weekly) -0.005


Company Profile
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.